PSA response to thalidomide in patients with advanced prostate cancer.
Leibowitz
Robert
R
Tucker
Steven J
SJ
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000601:surgery; D016879:Salvage Therapy; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome
D000726:Androgen Antagonists; D020533:Angiogenesis Inhibitors; D018931:Antineoplastic Agents, Hormonal; D013792:Thalidomide; D017430:Prostate-Specific Antigen